Dermata Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 48.33 K | $58.48 K | 100.00% | 1.25% |
| UBS GROUP AG | 05/05/2026 | 35.61 K | $43.09 K | 2,778.58% | 0.92% |
| WELCH & FORBES LLC | 05/01/2026 | 20.00 K | $24.20 K | 100.00% | 0.52% |
| MCF ADVISORS LLC | 05/11/2026 | 1.73 K | $2.10 K | 100.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 716 | $866 | -64.18% | 0.02% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 101 | $122 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $1 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CLEAR STREET GROUP INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Dermata Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of Dermata Therapeutics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 48,334
UBS Group AG: 35,608
WELCH & FORBES LLC: 20,000
MCF Advisors LLC: 1,732
Tower Research Capital LLC (TRC): 716
SBI Securities Co., Ltd.: 101
2.76% of Dermata Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 106.49 K shares in the last 24 months. This purchase volume represents approximately $141.63 K in transactions.